The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism

Brian J. Willett, Joe Grove, Oscar A MacLean, Craig Wilkie, Nicola Logan, Giuditta De Lorenzo, Wilhelm Furnon, Sam Scott, Maria Manali, Agnieszka Szemiel, Shirin Ashraf, Elen Vink, William Harvey, Chris Davis, Richard Orton, Joseph Hughes, Poppy Holland, Vanessa Silva, David Pascall, Kathryn Puxty, Ana da Silva Filipe, Gonzalo Yebra, Sharif Shaaban, Matthew T. G. Holden, Rute Maria Pinto, Rory Gunson, Kate Templeton, Pablo Murcia, Arvind H. Patel, The COVID-19 DeplOyed VaccinE (DOVE) Cohort Study investigators, The COVID-19 Genomics UK (COG-UK) Consortium, The G2P-UK National Virology Consortium, The Evaluation of Variants Affecting Deployed COVID-19 Vaccines (EVADE) investigators, John Haughney, David L. Robertson, Massimo Palmarini, Surajit Ray, Emma C. Thomson
doi: https://doi.org/10.1101/2022.01.03.21268111

Article Information

doi 
https://doi.org/10.1101/2022.01.03.21268111
History 
  • January 3, 2022.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Brian J. Willett1,#,*,
  2. Joe Grove1,*,
  3. Oscar A MacLean1,*,
  4. Craig Wilkie2,*,
  5. Nicola Logan1,*,
  6. Giuditta De Lorenzo1,*,
  7. Wilhelm Furnon1,*,
  8. Sam Scott1,*,
  9. Maria Manali1,*,
  10. Agnieszka Szemiel1,
  11. Shirin Ashraf1,
  12. Elen Vink1,
  13. William Harvey1,
  14. Chris Davis1,
  15. Richard Orton1,
  16. Joseph Hughes1,
  17. Poppy Holland3,
  18. Vanessa Silva3,
  19. David Pascall4,
  20. Kathryn Puxty3,
  21. Ana da Silva Filipe1,
  22. Gonzalo Yebra5,
  23. Sharif Shaaban5,
  24. Matthew T. G. Holden5,6,
  25. Rute Maria Pinto1,
  26. Rory Gunson3,
  27. Kate Templeton7,
  28. Pablo Murcia1,
  29. Arvind H. Patel1,
  30. The COVID-19 DeplOyed VaccinE (DOVE) Cohort Study investigators,
  31. The COVID-19 Genomics UK (COG-UK) Consortium***,
  32. The G2P-UK National Virology Consortium,
  33. The Evaluation of Variants Affecting Deployed COVID-19 Vaccines (EVADE) investigators,
  34. John Haughney3,**,
  35. David L. Robertson1,**,
  36. Massimo Palmarini1,**,
  37. Surajit Ray2,** and
  38. Emma C. Thomson1,3,8,#,**
  1. 1MRC-University of Glasgow Centre for Virus Research, UK, G61 1QH.
  2. 2School of Mathematics & Statistics, University of Glasgow, UK
  3. 3NHS Greater Glasgow & Clyde, Glasgow, UK
  4. 4MRC Biostatistics Unit, University of Cambridge
  5. 5Public Health Scotland
  6. 6School of Medicine, University of St Andrews
  7. 7NHS Lothian
  8. 8London School of Hygiene and Tropical Medicine, London, UK
  1. ↵#Corresponding authors: Professor Emma Thomson and Professor Brian Willett, MRC-University of Glasgow Centre for Virus Research, UK, G61 1QH. emma.thomson{at}glasgow.ac.uk and brian.willett{at}glasgow.ac.uk

  1. ↵* Contributed equally to the publication

  2. ↵** Contributed equally to the publication

Back to top
Posted January 03, 2022.
Download PDF
Data/Code
Email
The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism
Brian J. Willett, Joe Grove, Oscar A MacLean, Craig Wilkie, Nicola Logan, Giuditta De Lorenzo, Wilhelm Furnon, Sam Scott, Maria Manali, Agnieszka Szemiel, Shirin Ashraf, Elen Vink, William Harvey, Chris Davis, Richard Orton, Joseph Hughes, Poppy Holland, Vanessa Silva, David Pascall, Kathryn Puxty, Ana da Silva Filipe, Gonzalo Yebra, Sharif Shaaban, Matthew T. G. Holden, Rute Maria Pinto, Rory Gunson, Kate Templeton, Pablo Murcia, Arvind H. Patel, The COVID-19 DeplOyed VaccinE (DOVE) Cohort Study investigators, The COVID-19 Genomics UK (COG-UK) Consortium, The G2P-UK National Virology Consortium, The Evaluation of Variants Affecting Deployed COVID-19 Vaccines (EVADE) investigators, John Haughney, David L. Robertson, Massimo Palmarini, Surajit Ray, Emma C. Thomson
medRxiv 2022.01.03.21268111; doi: https://doi.org/10.1101/2022.01.03.21268111
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area